Neurosci Lett 268(2):101104 McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG (2006) Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinsons disease
doi: 10.3389/fphar.2017.00849 32 MorrisonR
Second, the EEG endpoint that defined the compounds activity is a population-level pattern in the recipient cortex, not a molecular readout meaning the discovery established a phenomenology, not a pathway
Jan 1995;47(1):312-318
GLP-1 medications are most effective when paired with healthy eating, regular physical activity, and behavioral changes
Gentle osmotic laxatives (polyethylene glycol, lactulose) and stool softeners are safe